Home › Trials › NCT06507150
Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

AI-assisted education for migraine management

Official title: AI-assisted Migraine Education: Efficacy, Safety and Patients' Acceptance

Run by Ente Ospedaliero Cantonale, Bellinzona · NCT06507150 · Data updated 2026-11-12

This study is testing if using AI to help educate people recently diagnosed with migraines can improve their understanding of the condition better than regular education.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment140 (estimated)
SponsorEnte Ospedaliero Cantonale, Bellinzona
Academic / other
Locations1 site (Lugano)
StatusRecruiting
StartedSeptember 1, 2024
Main results expectedJune 2027
Study endsJune 2027
Registry record updatedMarch 12, 2026
Trial IDNCT06507150 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 to 65 who have recently been diagnosed with migraine and have access to digital devices.

Probably not a fit

Patients with cognitive impairments or those unable to use the AI-powered learning platform may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate the effectiveness of AI-assisted migraine education compared to standard education in improving patients' understanding of their condition. It focuses on individuals aged 18 to 65 who have recently been diagnosed with migraine. The intervention involves using AI technology to provide personalized educational content, enhancing engagement and knowledge retention. By leveraging AI, the study seeks to improve diagnosis, predict migraine episodes, and optimize treatment adherence, ultimately aiming to reduce the stigma associated with migraines.

Why it matters

Potential benefit: If successful, this approach could significantly enhance patients' understanding and management of their migraines, leading to better health outcomes.

How similar studies have gone: While AI applications in healthcare are emerging, this specific approach to migraine education is relatively novel and has not been extensively tested in prior studies.

Who can join: the full rules

Show full inclusion / exclusion criteria 
Inclusion Criteria:

* aged between 18 and 65 years at the time of signing the informed consent
* Newly diagnosis of migraine, confirmed through the medical chart
* The participant must be capable of giving signed informed consent
* Access to a laptop, computer, smartphone, or tablet

Exclusion Criteria:

* Insufficient knowledge of the protocol language (italian)
* Patients with cognitive impairment and/or unable to use or access the AI-powered learning platform developed in this study.
* Vulnerable participants (e.g. minors, participants incapable of judgment or participants under tutelage)

Where it's running

  • Ente Ospedaliero Cantonale - Ospedale Regionale di Lugano
    Lugano, Switzerland     Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
View on ClinicalTrials.gov ↗ Find more trials like this →
Browse more
Migraine 167Ente Ospedaliero Cantonale, Bellinzona 25
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.